Skip to main content
. 2019 Jan 24;15(4):822–827. doi: 10.1080/21645515.2018.1551701

Table 2.

Immune response before and after varicella vaccination.

Characteristics CS1 CS2 CS3 Pooled CS LPS P valueb P valuec Difference % (95%CI)
Pre-vaccination                
Seropositive (n) 83 83 77 243 41 - - -
Seronegative (n) 242 245 246 733 128 - - -
Seropositive rate, % 25.54 25.30 23.84 24.90 24.26 0.8633 0.8594 -
(95% CI) (20.89–30.64) (20.69–30.37) (19.30–28.87) (22.21–27.73) (18.01–31.44)      
GMT (95% CI) 2.63 (2.48–2.79) 2.59 (2.45–2.74) 2.54 (2.41–2.67) 2.59 (2.51–2.67) 2.61 (2.40–2.84) 0.6507 0.8380 -
Post-vaccination                
Seroconversion rate, %(95% CI) 97.54 (95.21–98.93) 95.73 (92.94–97.65) 96.90 (94.38–98.51) 96.72 (95.40–97.75) 92.90 (87.93–96.28) 0.4208 0.0274 3.82 (0.55–8.81)
GMT (95% CI) 25.04 (22.85–27.44) 24.47 (22.35–26.78) 25.88 (23.61–28.36) 25.12 (23.83–26.47) 23.43 (20.74–26.47) 0.6928 0.3156 -
GMI (95% CI) 9.51 (8.72–10.37) 9.43 (8.65–10.29) 10.20 (9.36–11.10) 9.70 (9.23–10.20) 8.97 (7.93–10.15) 0.3891 0.2372 -

bThe P values were calculated for comparisons of the three consecutive CS groups and LPS group by ANOVA.

cThe P values were calculated for comparison of the pooled CS group and LPS group by Fisher’ exact test.